History

Printer-friendly

Founders of MTZ Clinical Research Sp. z o.o. have gained long-term experience in conduct of research and development projects. This experience was gained at research institutions, biopharmaceutical companies and Contract Research Organizations (CRO) in Canada, US and European countries.

MTZ Clinical Research is functioning as CRO with own Clinical Research Site.

·        2002 - Incorporation of MTZ Clinical Research Sp. z o.o.
 Zbigniew Proba, MSc, PhD became President.

He was a Postdoctoral Fellow at the Chemistry Department of McGill University, Montreal, Canada and later worked there as Research Associate. Dr. Zbigniew Proba acted as R&D Project Manager of Haemacure Corporation in Montreal and as President of MedSource Poland Ltd., company specialized in clinical research.

Teresa Brodniewicz, MSc, PhD became Scientific Affairs and Business Development Director and Vice President

Dr. Teresa Brodniewicz served as Scientific Director at Armand Frappier Blood Fractionation Center, Laval, Canada, and also as Vice President and CSO of Haemacure Corp., Canada. She acted as Director of Clinical Operations at Parexel International, Warsaw.

·        2002 – MTZ established a medical site (NZOZ) where clinical trial procedures are performed

·        2003 -  Katarzyna Jarus-Dziedzic, MD, PhD became Medical Director

Member of Department of Neurosurgery, Institute of Experimental and Clinical Medicine, of the Polish Academy of Sciences, Warsaw, Poland. She received The Bayer Company Foundation award under the patronage of the Polish Society of Neurosurgery for notable achievements in neurosurgery and individual Polish Science Foundation Prize for eminent researchers for their outstanding achievements.

·        2003 -  MTZ Clinical Research conducted first Bioequivalence Study

·        2003 -  MTZ Clinical Research conducted first Bioavailability Study

·        2004 -  MTZ Clinical Research conducted first Phase I Study

·        2004 -  Registration of subject  database

·        2007 -  Extensive renovation of the Clinical Site

·        2008 -  Teresa Brodniewicz, MSc, PhD became President

·        2008 -  Decision of MTZ Management to focus on early-staged studies:
             MTZ Clinical Research began acting as CRO

·        2008 -  Creation of independent Quality Assurance Department

·        2009 -  MTZ obtained a Certificate of Approval for Quality Management System EN ISO 9001:2008 from UKAS QUALITY MANAGEMENT company

·        2010 -  Extension of services by including Oncological Products Studies

·        2010 -  Opening of pharmacy equipped with a laminar flow cabinet